BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 33504754)

  • 1. [A case of spinal cord infarction accompanied with neuromyelitis optica spectrum pathophysiology].
    Katanazaka K; Chihara N; Akazawa S; Ueda T; Sekiguchi K; Matsumoto R
    Rinsho Shinkeigaku; 2021 Feb; 61(2):127-131. PubMed ID: 33504754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A case of neuromyelitis optica spectrum disorders associated with primary biliary cholangitis: a twelve year follow-up study].
    Sakai T; Kondo M; Kawana Y; Inoue R
    Rinsho Shinkeigaku; 2022 Mar; 62(3):190-197. PubMed ID: 35228461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The utility of diffusion-weighted imaging in patients with spinal cord infarction: difference from the findings of neuromyelitis optica spectrum disorder.
    Kobayashi M
    BMC Neurol; 2022 Oct; 22(1):382. PubMed ID: 36221057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brain and spinal cord lesion criteria distinguishes AQP4-positive neuromyelitis optica and MOG-positive disease from multiple sclerosis.
    Bensi C; Marrodan M; González A; Chertcoff A; Osa Sanz E; Chaves H; Schteinschnaider A; Correale J; Farez MF
    Mult Scler Relat Disord; 2018 Oct; 25():246-250. PubMed ID: 30144694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contribution of spinal cord biopsy to diagnosis of aquaporin-4 antibody positive neuromyelitis optica spectrum disorder.
    Ringelstein M; Metz I; Ruprecht K; Koch A; Rappold J; Ingwersen J; Mathys C; Jarius S; Brück W; Hartung HP; Paul F; Aktas O;
    Mult Scler; 2014 Jun; 20(7):882-8. PubMed ID: 24192218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A case of neuromyelitis optica spectrum disorder following seasonal influenza vaccination.
    Cho JH; Park Y; Woo N
    Mult Scler Relat Disord; 2019 May; 30():110-113. PubMed ID: 30769255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A case of suspected neuromyelitis optica spectrum disorder preceded by aseptic meningitis-like symptoms].
    Odachi K; Iio K; Uno K; Kawada N; Tomimoto H
    Rinsho Shinkeigaku; 2019 Nov; 59(11):736-739. PubMed ID: 31656264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A case of neuromyelitis optica presenting marked pleocytosis and hypoglycorrhachia].
    Fujikura M; Yokokawa K; Shizukawa H; Shimohama S
    Rinsho Shinkeigaku; 2016 Aug; 56(8):569-72. PubMed ID: 27477573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A case of neuromyelitis optica associated with anti-aquaporin 4 antibody and other autoantibodies].
    Maruta K; Sonoda Y; Uchida Y; Takahashi T; Fukunaga H
    Nihon Ronen Igakkai Zasshi; 2012; 49(4):491-5. PubMed ID: 23269030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. First manifestation of AQP4-IgG-positive neuromyelitis optica spectrum disorder following the COVID-19 mRNA vaccine BNT162b2.
    Umezawa S; Ioka K; Aizawa S; Tashiro Y; Yoshizawa K
    Neurol Sci; 2023 Feb; 44(2):451-455. PubMed ID: 36289118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuromyelitis optica spectrum disorder coexisting with ankylosing spondylitis: A case report.
    Lin J; Zhang J; Liu X; Gong X; Li A; Zhou D; Hong Z
    Mult Scler Relat Disord; 2020 May; 40():101979. PubMed ID: 32036261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. AQP4-IgG-seropositive neuromyelitis optica spectrum disorder (NMOSD) coexisting with anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis: A case report and literature review.
    Tao S; Zhang Y; Ye H; Guo D
    Mult Scler Relat Disord; 2019 Oct; 35():185-192. PubMed ID: 31398657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Seroconversion of anti-aquaporin-4 antibody in a patient with neuromyelitis optica spectrum disorder: a case report].
    Shimoyama K; Akahori M; Ishio Y; Yanagihara C
    Rinsho Shinkeigaku; 2022 May; 62(5):351-356. PubMed ID: 35474282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunoadsorption plasmapheresis treatment for the recurrent exacerbation of neuromyelitis optica spectrum disorder with a fluctuating anti-aquaporin-4 antibody level.
    Nishimura H; Enokida H; Sakamoto T; Takahashi T; Hayami H; Nakagawa M
    J Artif Organs; 2018 Sep; 21(3):378-382. PubMed ID: 29675599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuromyelitis optica study model based on chronic infusion of autoantibodies in rat cerebrospinal fluid.
    Marignier R; Ruiz A; Cavagna S; Nicole A; Watrin C; Touret M; Parrot S; Malleret G; Peyron C; Benetollo C; Auvergnon N; Vukusic S; Giraudon P
    J Neuroinflammation; 2016 May; 13(1):111. PubMed ID: 27193196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A case of neuromyelitis optica spectrum disorder with persistent nausea and repeated syncope].
    Endo Y; Hayashi K; Ikawa M; Yamamura O; Ookura K; Hamano T
    Rinsho Shinkeigaku; 2020 Feb; 60(2):142-145. PubMed ID: 31956194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pontine hemorrhage accompanied by neuromyelitis optica spectrum disorder.
    Kamo H; Ueno Y; Sugiyama M; Miyamoto N; Yamashiro K; Tanaka R; Yokoyama K; Hattori N
    J Neuroimmunol; 2019 May; 330():19-22. PubMed ID: 30769213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influenza-associated monophasic neuromyelitis optica.
    Nakamura Y; Ikeda K; Yoshii Y; Ito H; Hirayama T; Kawabe K; Kano O; Iwasaki Y
    Intern Med; 2011; 50(15):1605-9. PubMed ID: 21804290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Neuromyelitis optica spectrum disorder: a case report].
    Mitsuyama T; Yoneyama T; Suzuki S; Kagawa M; Kawamata T
    No Shinkei Geka; 2012 Apr; 40(4):337-42. PubMed ID: 22466233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuromyelitis optica spectrum disorder with increased aquaporin-4 microparticles prior to autoantibodies in cerebrospinal fluid: a case report.
    Bejerot S; Hesselmark E; Mobarrez F; Wallén H; Hietala MA; Nybom R; Wetterberg L
    J Med Case Rep; 2019 Jan; 13(1):27. PubMed ID: 30696485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.